- Products
- About Us
- News & Events
- Contact Us
- 888.882.5522
-
0
0
Mid Range AED II
Anti-epileptic 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Felbamate | 50 | µg/mL | 25 days |
| Gabapentin | 10 | µg/mL | 25 days |
| Lacosamide | 5 | µg/mL | 25 days |
| Lamotrigine | 5 | µg/mL | 25 days |
| Levetiracetam | 15 | µg/mL | 25 days |
| Oxcarbazepine | 2 | µg/mL | 25 days |
| 10-OH-Carbazepine | 20 | µg/mL | 25 days |
| Pregabalin | 5 | µg/mL | 25 days |
| Rufinamide | 5 | µg/mL | 25 days |
| Tiagabine | 80 | µg/mL | 25 days |
| Topiramate | 15 | µg/mL | 25 days |
| Zonisamide | 20 | µg/mL | 25 days |
High Range AED II
Anti-epileptic 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Felbamate | 100 | µg/mL | 25 days |
| Gabapentin | 40 | µg/mL | 25 days |
| Lacosamide | 20 | µg/mL | 25 days |
| Lamotrigine | 20 | µg/mL | 25 days |
| Levetiracetam | 40 | µg/mL | 25 days |
| Oxcarbazepine | 10 | µg/mL | 25 days |
| 10-OH-Carbazepine | 60 | µg/mL | 25 days |
| Pregabalin | 15 | µg/mL | 25 days |
| Rufinamide | 40 | µg/mL | 25 days |
| Tiagabine | 140 | µg/mL | 25 days |
| Topiramate | 50 | µg/mL | 25 days |
| Zonisamide | 60 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Caspofungin | 1.5 | µg/mL | 25 days |
| Fluconazole | 4 | µg/mL | 25 days |
| 5-Flucytosine | 30 | µg/mL | 25 days |
| Itraconazole | 1.5 | µg/mL | 25 days |
| *Hydroxy-Itraconazole | 1.5 | µg/mL | 25 days |
| Posaconazole | 1.5 | µg/mL | 25 days |
| Voriconazole | 1.5 | µg/mL | 25 days |
Antifungals Level 2
100% Real Human Matrix Serum Antifungals Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Caspofungin | 9 | µg/mL | 25 days |
| Fluconazole | 20 | µg/mL | 25 days |
| 5-Flucytosine | 65 | µg/mL | 25 days |
| Itraconazole | 5 | µg/mL | 25 days |
| *Hydroxy-Itraconazole | 5 | µg/mL | 25 days |
| Posaconazole | 5 | µg/mL | 25 days |
| Voriconazole | 5 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 0 | ng/mL | 30 days |
| d-Methamphetamine | 0 | ng/mL | 30 days |
| Benzoylecgonine | 0 | ng/mL | 30 days |
| Morphine | 0 | ng/mL | 30 days |
| Oxazepam | 0 | ng/mL | 30 days |
| Phencyclidine (PCP) | 0 | ng/mL | 30 days |
| Secobarbital | 0 | ng/mL | 30 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC | 0 | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aripiprazole | 100 | ng/mL | 25 days |
| Clozapine | 100 | ng/mL | 25 days |
| Desmethylclozapine | 100 | ng/mL | 25 days |
| Haloperidol | 10 | ng/mL | 25 days |
| Reduced Haloperidol | 10 | ng/mL | 25 days |
| Olanzapine | 50 | ng/mL | 25 days |
| Quetiapine | 100 | ng/mL | 25 days |
| Risperidone | 50 | ng/mL | 25 days |
| 9-Hydroxyrisperidone | 50 | ng/mL | 25 days |
| Ziprasidone | 50 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aripiprazole | 400 | ng/mL | 25 days |
| Clozapine | 400 | ng/mL | 25 days |
| Desmethylclozapine | 400 | ng/mL | 25 days |
| Haloperidol | 50 | ng/mL | 25 days |
| Reduced Haloperidol | 50 | ng/mL | 25 days |
| Olanzapine | 100 | ng/mL | 25 days |
| Quetiapine | 400 | ng/mL | 25 days |
| Risperidone | 150 | ng/mL | 25 days |
| 9-Hydroxyrisperidone | 150 | ng/mL | 25 days |
| Ziprasidone | 150 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 1.5 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 6.0 | µg/dL | 25 days |
| Cortisone | 1.5 | µg/dL | 25 days |
| Corticosterone | 300 | ng/dL | 25 days |
| 11-Deoxycortisol | 100 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 3 | ng/mL | 25 days |
| Progesterone | 7.5 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 300 | ng/dL | 25 days |
| Testosterone | 300 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 4 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 20 | µg/dL | 25 days |
| Cortisone | 4 | µg/dL | 25 days |
| Corticosterone | 800 | ng/dL | 25 days |
| 11-Deoxycortisol | 300 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 8 | ng/mL | 25 days |
| Progesterone | 20 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 800 | ng/dL | 25 days |
| Testosterone | 800 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methotrexate | 0.05 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methotrexate | 0.075 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methotrexate | 0.5 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methotrexate | 0.75 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methylmalonic Acid (MMA) | 0.2 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Methylmalonic Acid (MMA) | 1.0 | µmol/L | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Pentobarbital | 20 | µg/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Bupropion | 70 | ng/mL | n/a |
| Citalopram | 70 | ng/mL | 25 |
| Duloxetine | 150 | ng/mL | 25 |
| Fluoxetine | 150 | ng/mL | 25 |
| Norfluoxetine | 150 | ng/mL | 25 |
| Fluvoxamine | 100 | ng/mL | 25 |
| Paroxetine | 100 | ng/mL | 25 |
| Sertraline | 100 | ng/mL | 25 |
| Desmethylsertraline | 100 | ng/mL | 25 |
| Venlafaxine | 100 | ng/mL | 25 |
| Desmethylvenlafaxine | 100 | ng/mL | 25 |
High Range SSRI 7 Plus
100% Real Human Matrix Serum SSRI Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Bupropion | 150 | ng/mL | n/a |
| Citalopram | 150 | ng/mL | 25 |
| Duloxetine | 600 | ng/mL | 25 |
| Fluoxetine | 600 | ng/mL | 25 |
| Norfluoxetine | 600 | ng/mL | 25 |
| Fluvoxamine | 1,000 | ng/mL | 25 |
| Paroxetine | 300 | ng/mL | 25 |
| Sertraline | 300 | ng/mL | 25 |
| Desmethylsertraline | 300 | ng/mL | 25 |
| Venlafaxine | 500 | ng/mL | 25 |
| Desmethylvenlafaxine | 500 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | 120 | ng/mL | 30 days |
| Diazepam | 0.9 | µg/mL | 30 days |
| Secobarbital | 0.1 | µg/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | TCAs | 480 | ng/mL | 30 days |
| Diazepam | 0.38 | µg/mL | 30 days |
| Secobarbital | 3.6 | µg/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 0.5 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 2.5 | µg/dL | 25 days |
| Cortisone | 0.6 | µg/dL | 25 days |
| Corticosterone | 100 | µg/dL | 25 days |
| 11-Deoxycortisol | 40 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 1.0 | ng/mL | 25 days |
| Progesterone | 2.5 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 100 | ng/dL | 25 days |
| Testosterone | 100 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 1.0 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 5.0 | µg/dL | 25 days |
| Cortisone | 1.2 | µg/dL | 25 days |
| Corticosterone | 200 | ng/dL | 25 days |
| 11-Deoxycortisol | 80 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 2.0 | ng/mL | 25 days |
| Progesterone | 5.0 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 200 | ng/dL | 25 days |
| Testosterone | 200 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 2.5 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 12.5 | µg/dL | 25 days |
| Cortisone | 3 | µg/dL | 25 days |
| Corticosterone | 500 | ng/dL | 25 days |
| 11-Deoxycortisol | 200 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 5 | ng/mL | 25 days |
| Progesterone | 12.5 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 500 | ng/dL | 25 days |
| Testosterone | 500 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 5 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 25 | µg/dL | 25 days |
| Cortisone | 6 | µg/dL | 25 days |
| Corticosterone | 1,000 | ng/dL | 25 days |
| 11-Deoxycortisol | 400 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 10 | ng/mL | 25 days |
| Progesterone | 25 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 1,000 | ng/dL | 25 days |
| Testosterone | 1,000 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aluminum | 6.5 - 15.3 | ng/mL | 30 days |
| Cadmium | 0.13 - 0.21 | ng/mL | 30 days |
| Calcium | 6.3 - 10.5 | mg/dL | 30 days |
| Chromium | 0.12 - 0.20 | ng/mL | 30 days |
| Copper | 0.81 - 1.35 | µg/mL | 30 days |
| Iron | 46.5 - 77.5 | µg/dL | 30 days |
| Magnesium | 12.0 - 20.0 | µg/mL | 30 days |
| Manganese | 0.35 - 0.59 | ng/mL | 30 days |
| Nickel | 0.30 - 0.50 | ng/mL | 30 days |
| Selenium | 76 - 126 | ng/mL | 30 days |
| Silver | 0.09 - 0.15 | ng/mL | 30 days |
| Zinc | 0.51 - 0.85 | µg/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aluminum | 161 - 241 | ng/mL | 30 days |
| Cadmium | 7.2 - 10.8 | ng/mL | 30 days |
| Calcium | 10.2 - 15.2 | mg/dL | 30 days |
| Chromium | 1.82 - 2.72 | ng/mL | 30 days |
| Copper | 2.4 - 3.7 | µg/mL | 30 days |
| Iron | 160 - 240 | µg/dL | 30 days |
| Magnesium | 34.4 - 51.6 | µg/mL | 30 days |
| Manganese | 2.01 - 3.01 | ng/mL | 30 days |
| Nickel | 4.6 - 6.9 | ng/mL | 30 days |
| Selenium | 225 - 337 | ng/mL | 30 days |
| Silver | 8.5 - 12.7 | ng/mL | 30 days |
| Zinc | 2.11 - 3.17 | µg/mL | 30 days |
Mid Range Tricyclic Antidepressants VI
100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | 100 | ng/mL | 30 days |
| Doxepin | 100 | ng/mL | 30 days |
| N-Desmethyldoxepin | 100 | ng/mL | 30 days |
| Imipramine | 100 | ng/mL | 30 days |
| Desipramine | 100 | ng/mL | 30 days |
| Nortriptyline | 100 | ng/mL | 30 days |
High Range Tricyclic Antidepressants VI
100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | 400 | ng/mL | 30 days |
| Doxepin | 400 | ng/mL | 30 days |
| N-Desmethyldoxepin | 400 | ng/mL | 30 days |
| Imipramine | 400 | ng/mL | 30 days |
| Desipramine | 400 | ng/mL | 30 days |
| Nortriptyline | 400 | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| 25-Hydroxy Vitamin D2 (25-OH-D2) | 10 | ng/mL | 25 days |
| 25-Hydroxy Vitamin D3 (25-OH-D3) | 10 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| 25-Hydroxy Vitamin D2 (25-OH-D2) | 30 | ng/mL | 25 days |
| 25-Hydroxy Vitamin D3 (25-OH-D3) | 30 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| 25-Hydroxy Vitamin D2 (25-OH-D2) | 73 | ng/mL | 25 days |
| 25-Hydroxy Vitamin D3 (25-OH-D3) | 73 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Retinol (Vitamin A) | 450 | ng/mL | 25 days |
| Retinyl Palmitate (Vitamin A) New | 50 | ng/mL | 25 days |
| α-Tocopherol (Vitamin E) | 6 | µg/mL | 25 days |
| γ-Tocopherol (Vitamin E) New | 2 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Retinol (Vitamin A) | 1,500 | ng/mL | 25 days |
| Retinyl Palmitate New | 150 | ng/mL | 25 days |
| α-Tocopherol (Vitamin E) | 30 | µg/mL | 25 days |
| γ-Tocopherol (Vitamin E) New | 4.5 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Acetone | 80 | mg/dL | 25 days |
| Ethanol | 150 | mg/dL | 25 days |
| Ethylene Glycol | 80 | mg/dL | 25days |
| Isopropanol | 80 | mg/dL | 25 days |
| Methanol | 40 | mg/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Alprazolam | 37.5 | ng/mL | 25 |
| Amobarbital | 90 | ng/mL | 25 |
| d-Amphetamine | 11.25 | ng/mL | 25 |
| d-Methamphetamine | 11.25 | ng/mL | 25 |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 11.25 | ng/mL | 25 |
| Buprenorphine | 6 | ng/mL | 14 |
| Butalbital | 90 | ng/mL | 25 |
| Carisoprodol | 90 | ng/mL | 25 |
| Cocaine | 6 | ng/mL | 25 |
| Benzoylecgonine | 6 | ng/mL | 25 |
| Codeine | 11.25 | ng/mL | 25 |
| Diazepam | 37.5 | ng/mL | 25 |
| Ethanol | 75 | mg/dL | 25 |
| Fentanyl | 6 | ng/mL | 25 |
| Hydrocodone | 11.25 | ng/mL | 25 |
| Hydromorphone | 11.25 | ng/mL | 25 |
| Lorazepam | 37.5 | ng/mL | 25 |
| Methadone | 37.5 | ng/mL | 25 |
| Morphine | 11.25 | ng/mL | 25 |
| 6-Monoacetylmorphine (6-MAM) | 1.5 | ng/mL | 25 |
| Oxazepam | 37.5 | ng/mL | 25 |
| Oxycodone | 11.25 | ng/mL | 25 |
| Oxymorphone | 11.25 | ng/mL | 25 |
| Pentobarbital | 90 | ng/mL | 25 |
| Phencyclidine (PCP) | 1.5 | ng/mL | 25 |
| Phenobarbital | 90 | ng/mL | 25 |
| Propoxyphene | 37.5 | ng/mL | 25 |
| Secobarbital | 90 | ng/mL | 25 |
| Tapentadol | 37.5 | ng/mL | 25 |
| Temazepam | 37.5 | ng/mL | 25 |
| Tramadol | 37.5 | ng/mL | 25 |
| Zolpidem | 37.5 | ng/mL | 25 |
| (-)-Delta-9-THC | 1.5 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Alprazolam | 62.5 | ng/mL | 25 |
| Amobarbital | 150 | ng/mL | 25 |
| d-Amphetamine | 18.75 | ng/mL | 25 |
| d-Methamphetamine | 18.75 | ng/mL | 25 |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 18.75 | ng/mL | 25 |
| Buprenorphine | 10 | ng/mL | 14 |
| Butalbital | 150 | ng/mL | 25 |
| Carisoprodol | 150 | ng/mL | 25 |
| Cocaine | 10 | ng/mL | 25 |
| Benzoylecgonine | 10 | ng/mL | 25 |
| Codeine | 18.75 | ng/mL | 25 |
| Diazepam | 62.5 | ng/mL | 25 |
| Ethanol | 125 | mg/dL | 25 |
| Fentanyl | 10 | ng/mL | 25 |
| Hydrocodone | 18.75 | ng/mL | 25 |
| Hydromorphone | 18.75 | ng/mL | 25 |
| Lorazepam | 62.5 | ng/mL | 25 |
| Methadone | 62.5 | ng/mL | 25 |
| Morphine | 18.75 | ng/mL | 25 |
| 6-Monoacetylmorphine (6-MAM) | 2.5 | ng/mL | 25 |
| Oxazepam | 62.5 | ng/mL | 25 |
| Oxycodone | 18.75 | ng/mL | 25 |
| Oxymorphone | 18.75 | ng/mL | 25 |
| Pentobarbital | 150 | ng/mL | 25 |
| Phencyclidine (PCP) | 2.5 | ng/mL | 25 |
| Phenobarbital | 150 | ng/mL | 25 |
| Propoxyphene | 62.5 | ng/mL | 25 |
| Secobarbital | 150 | ng/mL | 25 |
| Tapentadol | 62.5 | ng/mL | 25 |
| Temazepam | 62.5 | ng/mL | 25 |
| Tramadol | 62.5 | ng/mL | 25 |
| Zolpidem | 62.5 | ng/mL | 25 |
| (-)-Delta-9-THC | 2.5 | ng/mL | 14 |
DOA (Drugs of Abuse) 50% Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 25 | ng/mL | 25 days |
| d-Methamphetamine | 25 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 10 | ng/mL | 25 days |
| Methadone | 2.5 | ng/mL | 25 days |
| Morphine | 20 | ng/mL | 25 days |
| Oxazepam | 25 | ng/mL | 25 days |
| Phencyclidine (PCP) | 5 | ng/mL | 25 days |
| Propoxyphene | 20 | ng/mL | 25 days |
| Secobarbital | 15 | ng/mL | 25 days |
| Delta-9-THC | 2 | ng/mL | 14 days |
DOA (Drugs of Abuse) Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 50 | ng/mL | 25 days |
| d-Methamphetamine | 50 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 20 | ng/mL | 25 days |
| Methadone | 5 | ng/mL | 25 days |
| Morphine | 40 | ng/mL | 25 days |
| Oxazepam | 50 | ng/mL | 25 days |
| Phencyclidine (PCP) | 10 | ng/mL | 25 days |
| Propoxyphene | 40 | ng/mL | 25 days |
| Secobarbital | 30 | ng/mL | 25 days |
| Delta-9-THC | 4 | ng/mL | 14 days |
DOA (Drugs of Abuse) 200% Cutoff
Cannabinoid SMx (Specialty Matrix) SMx Oral Fluid Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 100 | ng/mL | 25 days |
| d-Methamphetamine | 100 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 40 | ng/mL | 25 days |
| Methadone | 10 | ng/mL | 25 days |
| Morphine | 80 | ng/mL | 25 days |
| Oxazepam | 100 | ng/mL | 25 days |
| Phencyclidine (PCP) | 20 | ng/mL | 25 days |
| Propoxyphene | 80 | ng/mL | 25 days |
| Secobarbital | 60 | ng/mL | 25 days |
| Delta-9-THC | 8 | ng/mL | 14 days |
Benzodiazepines Plus 100 ng/mL
Benzodiazepines 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Alprazolam | 100 | ng/mL | 25 days |
| α-Hydroxyalprazolam | 100 | ng/mL | 25 days |
| Chlordiazepoxide | 100 | ng/mL | 25 days |
| Clobazam | 100 | ng/mL | 25 days |
| Clonazepam | 100 | ng/mL | 25 days |
| 7-Aminoclonazepam | 100 | ng/mL | n/a |
| Diazepam | 100 | ng/mL | 25 days |
| Nordiazepam | 100 | ng/mL | 25 days |
| Estazolam | 100 | ng/mL | 25 days |
| Flunitrazepam | 100 | ng/mL | 25 days |
| 7-Aminoflunitrazepam | 100 | ng/mL | n/a |
| Flurazepam | 100 | ng/mL | 25 days |
| Desalkylflurazepam | 100 | ng/mL | 25 days |
| Hydroxyethylflurazepam | 100 | ng/mL | 25 days |
| Lorazepam | 100 | ng/mL | 25 days |
| Midazolam | 100 | ng/mL | 25 days |
| Nitrazepam | 100 | ng/mL | 25 days |
| 7-Aminonitrazepam | 100 | ng/mL | n/a |
| Oxazepam | 100 | ng/mL | 25 days |
| Temazepam | 100 | ng/mL | 25 days |
| Triazolam | 100 | ng/mL | 25 days |
| α-Hydroxytriazolam | 100 | ng/mL | 25 days |
| Zolpidem | 100 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 100 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 100 | ng/mL | 30 days |
| d-Methamphetamine | 100 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 100 | ng/mL | 30 days |
| Cocaine | 100 | ng/mL | 30 days |
| Benzoylecgonine | 100 | ng/mL | 30 days |
| Cocaethylene | 100 | ng/mL | 30 days |
| Codeine | 100 | ng/mL | 30 days |
| Hydrocodone | 100 | ng/mL | 30 days |
| Morphine | 100 | ng/mL | 30 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 500 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 500 | ng/mL | 30 days |
| d-Methamphetamine | 500 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 500 | ng/mL | 30 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 500 | ng/mL | 30 days |
| Cocaine | 500 | ng/mL | 30 days |
| Benzoylecgonine (BE) | 500 | ng/mL | 30 days |
| Cocaethylene | 500 | ng/mL | 30 days |
| Codeine | 500 | ng/mL | 30 days |
| Hydrocodone | 500 | ng/mL | 30 days |
| Morphine | 500 | ng/mL | 30 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | xx | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Ethanol | 80 | mg/dL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| 4-ANPP | 2 | ng/mL | 25 |
| Acetylfentanyl | 2 | ng/mL | 25 |
| Acrylfentanyl | 2 | ng/mL | 25 |
| Alfentanil | 2 | ng/mL | 25 |
| Butyryl Fentanyl | 2 | ng/mL | 25 |
| Carfentanyl | 2 | ng/mL | 25 |
| cis-3-Methylfentanyl | 2 | ng/mL | 25 |
| Crotonylfentanyl | 2 | ng/mL | 25 |
| Fentanyl | 2 | ng/mL | 25 |
| Furanyl Fentanyl | 2 | ng/mL | 25 |
| Isobutyrylfentanyl | 2 | ng/mL | 25 |
| m-Methylmethoxyacetylfentanyl | 2 | ng/mL | 25 |
| Methoxyacetylfentanyl | 2 | ng/mL | 25 |
| Norfentanyl | 2 | ng/mL | 25 |
| Ocfentanyl | 2 | ng/mL | 25 |
| ortho-Fluorofentanyl | 2 | ng/mL | 25 |
| para-Fluorobutyrylfentanyl | 2 | ng/mL | 25 |
| para-Fluoroisobutyrylfentanyl | 2 | ng/mL | 25 |
| para-Fluorofentanyl | 2 | ng/mL | 25 |
| Sufentanil | 2 | ng/mL | 25 |
| Tetrahydrofuran Fentanyl | 2 | ng/mL | 25 |
| U-47700 | 2 | ng/mL | 25 |
| U-49900 | 2 | ng/mL | 25 |
| U51754 | 2 | ng/mL | 25 |
| Valerylfentanyl | 2 | ng/mL | 25 |
| Cyclopropylfentanyl | 2 | ng/mL | 25 |
Immunosuppressants Level 1 (3mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 90 | ng/mL | 30 days |
| Everolimus | 4 | ng/mL | 25 days |
| Sirolimus | 4 | ng/mL | 25 days |
| Tacrolimus | 4 | ng/mL | 25 days |
Immunosuppressants Level 2 (3mL)
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 500 | ng/mL | 30 days |
| Everolimus | 15 | ng/mL | 25 days |
| Sirolimus | 15 | ng/mL | 25 days |
| Tacrolimus | 15 | ng/mL | 25 days |
Immunosuppressants Level 3 (3mL)
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 1,200 | ng/mL | 30 days |
| Everolimus | 25 | ng/mL | 25 days |
| Sirolimus | 25 | ng/mL | 25 days |
| Tacrolimus | 25 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Lead | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Lead | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Lead | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Arsenic | (see IFU) | 30 days | |
| Cadmium | (see IFU) | 30 days | |
| Chromium | (see IFU) | 30 days | |
| Lead | (see IFU) | 30 days | |
| Manganese | (see IFU) | 30 days | |
| Mercury | (see IFU) | 30 days | |
| Selenium | (see IFU) | 30 days | |
| Thallium | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Arsenic | (see IFU) | 30 days | |
| Cadmium | (see IFU) | 30 days | |
| Chromium | (see IFU) | 30 days | |
| Lead | (see IFU) | 30 days | |
| Manganese | (see IFU) | 30 days | |
| Mercury | (see IFU) | 30 days | |
| Selenium | (see IFU) | 30 days | |
| Thallium | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Arsenic | (see IFU) | 30 days | |
| Cadmium | (see IFU) | 30 days | |
| Chromium | (see IFU) | 30 days | |
| Lead | (see IFU) | 30 days | |
| Manganese | (see IFU) | 30 days | |
| Mercury | (see IFU) | 30 days | |
| Selenium | (see IFU) | 30 days | |
| Thallium | (see IFU) | 30 days |
Pain Management 100 (PM 100)
100% Real Human Matrix Drugs of Abuse Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Norbuprenorphine | 10 | ng/mL | n/a |
| Codeine | 100 | ng/mL | 25 days |
| Fentanyl | 10 | ng/mL | 25 days |
| Norfentanyl | 10 | ng/mL | 25 days |
| Hydrocodone | 100 | ng/mL | 25 days |
| Hydromorphone | 100 | ng/mL | 25 days |
| Meperidine | 100 | ng/mL | 25 days |
| Methadone | 100 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 100 | ng/mL | n/a |
| Morphine | 100 | ng/mL | 25 days |
| Oxycodone | 100 | ng/mL | 25 days |
| Oxymorphone | 100 | ng/mL | 25 days |
| Tapentadol | 100 | ng/mL | 25 days |
| Tramadol | 100 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Acetone | 80 | mg/dL | 30 days |
| Ethanol | 150 | mg/dL | 30 days |
| Ethylene Glycol | 80 | mg/dL | 30 days |
| Isopropanol | 80 | mg/dL | 30 days |
| Methanol | 40 | mg/dL | 30 days |
Amphetamines Panel Level 1
Amphetamines Panel 100% Real Human Matrix Urine Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 350 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 350 | ng/mL | 25 days |
| d-Methamphetamine | 350 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 350 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 350 | ng/mL | 25 days |
| Methylephedrine | 350 | ng/mL | 25 days |
| (-)-Ephedrine | 350 | ng/mL | 25 days |
| Phendimetrazine | 350 | ng/mL | 25 days |
| Phenmetrazine | 350 | ng/mL | 25 days |
| Phentermine | 350 | ng/mL | 25 days |
| Phenylpropanolamine | 350 | ng/mL | 25 days |
| (+)-Pseudoephedrine | 350 | ng/mL | 25 days |
| Selegiline | 350 | ng/mL | 25 days |
Amphetamines Panel Level 2
Amphetamines Panel 100% Real Human Matrix Urine Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 700 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 700 | ng/mL | 25 days |
| d-Methamphetamine | 700 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 700 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 700 | ng/mL | 25 days |
| Methylephedrine | 700 | ng/mL | 25 days |
| (-)-Ephedrine | 700 | ng/mL | 25 days |
| Phendimetrazine | 700 | ng/mL | 25 days |
| Phenmetrazine | 700 | ng/mL | 25 days |
| Phentermine | 700 | ng/mL | 25 days |
| Phenylpropanolamine | 700 | ng/mL | 25 days |
| (+)-Pseudoephedrine | 700 | ng/mL | 25 days |
| Selegiline | 700 | ng/mL | 25 days |
Benzodiazepines Plus 100 ng/mL
Benzodiazepines 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Alprazolam | 100 | ng/mL | 25 days |
| α-Hydroxyalprazolam | 100 | ng/mL | 25 days |
| Chlordiazepoxide | 100 | ng/mL | 25 days |
| Norchlordiazepoxide | 100 | ng/mL | 25 days |
| Clobazam | 100 | ng/mL | 25 days |
| Clonazepam | 100 | ng/mL | 25 days |
| 7-Aminoclonazepam | 100 | ng/mL | n/a |
| Diazepam | 100 | ng/mL | 25 days |
| Nordiazepam | 100 | ng/mL | 25 days |
| Estazolam | 100 | ng/mL | 25 days |
| Flunitrazepam | 100 | ng/mL | 25 days |
| 7-Aminoflunitrazepam | 100 | ng/mL | n/a |
| Flurazepam | 100 | ng/mL | 25 days |
| Desalkylflurazepam | 100 | ng/mL | 25 days |
| Hydroxyethylflurazepam | 100 | ng/mL | 25 days |
| Lorazepam | 100 | ng/mL | 25 days |
| Midazolam | 100 | ng/mL | 25 days |
| α-Hydroxymidazolam | 100 | ng/mL | 25 days |
| Nitrazepam | 100 | ng/mL | 25 days |
| 7-Aminonitrazepam | 100 | ng/mL | n/a |
| Oxazepam | 100 | ng/mL | 25 days |
| Temazepam | 100 | ng/mL | 25 days |
| Traizolam | 100 | ng/mL | 25 days |
| α-Hydroxytriazolam | 100 | ng/mL | 25 days |
| Zolpidem | 100 | ng/mL | 25 days |
Benzodiazepines Plus 400 ng/mL
Benzodiazepines 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Alprazolam | 400 | ng/mL | 25 days |
| α-Hydroxyalprazolam | 400 | ng/mL | 25 days |
| Chlordiazepoxide | 400 | ng/mL | 25 days |
| Norchlordiazepoxide | 400 | ng/mL | 25 days |
| Clobazam | 400 | ng/mL | 25 days |
| 7-Aminoclonazepam | 400 | ng/mL | n/a |
| Diazepam | 400 | ng/mL | 25 days |
| Nordiazepam | 400 | ng/mL | 25 days |
| Estazolam | 400 | ng/mL | 25 days |
| Flunitrazepam | 400 | ng/mL | 25 days |
| 7-Aminoflunitrazepam | 400 | ng/mL | n/a |
| Flurazepam | 400 | ng/mL | 25 days |
| Desalkylflurazepam | 400 | ng/mL | 25 days |
| Hydroxyethylflurazepam | 400 | ng/mL | 25 days |
| Lorazepam | 400 | ng/mL | 25 days |
| Midazolam | 400 | ng/mL | 25 days |
| α-Hydroxymidazolam | 400 | ng/mL | 25 days |
| Nitrazepam | 400 | ng/mL | 25 days |
| 7-Aminonitrazepam | 400 | ng/mL | n/a |
| Oxazepam | 400 | ng/mL | 25 days |
| Temazepam | 400 | ng/mL | 25 days |
| Triazolam | 400 | ng/mL | 25 days |
| α-Hydroxytriazolam | 400 | ng/mL | 25 days |
| Zolpidem | 400 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Methamphetamine | 225 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 50 | ng/mL | 25 days |
| Methadone | 50 | ng/mL | 25 days |
| Methaqualone | 50 | ng/mL | 25 days |
| Morphine | 225 | ng/mL | 25 days |
| Oxazepam | 50 | ng/mL | 25 days |
| Phencyclidine (PCP) | 5 | ng/mL | 25 days |
| Propoxyphene | 50 | ng/mL | 25 days |
| Secobarbital | 50 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 10 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Methamphetamine | 375 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 112.5 | ng/mL | 25 days |
| Methadone | 112.5 | ng/mL | 25 days |
| Methaqualone | 112.5 | ng/mL | 25 days |
| Morphine | 375 | ng/mL | 25 days |
| Oxazepam | 75 | ng/mL | 25 days |
| Phencyclidine (PCP) | 9.375 | ng/mL | 25 days |
| Propoxyphene | 112.5 | ng/mL | 25 days |
| Secobarbital | 75 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 15 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Methamphetamine | 750 | ng/mL | 25 days |
| Benzoylecgonine | 225 | ng/mL | 25 days |
| Methadone | 225 | ng/mL | 25 days |
| Methaqualone | 225 | ng/mL | 25 days |
| Morphine | 1,500 | ng/mL | 25 days |
| Oxazepam | 150 | ng/mL | 25 days |
| Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
| Propoxyphene | 225 | ng/mL | 25 days |
| Secobarbital | 150 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 37.5 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Methamphetamine | 1,250 | ng/mL | 25 days |
| Benzoylecgonine | 375 | ng/mL | 25 days |
| Methadone | 375 | ng/mL | 25 days |
| Methaqualone | 375 | ng/mL | 25 days |
| Morphine | 2,500 | ng/mL | 25 days |
| Oxazepam | 250 | ng/mL | 25 days |
| Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
| Propoxyphene | 375 | ng/mL | 25 days |
| Secobarbital | 250 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 62.5 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Methamphetamine | 1,500 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 625 | ng/mL | 25 days |
| Methadone | 625 | ng/mL | 25 days |
| Methaqualone | 625 | ng/mL | 25 days |
| Morphine | 3,000 | ng/mL | 25 days |
| Oxazepam | 375 | ng/mL | 25 days |
| Phencyclidine (PCP) | 93.75 | ng/mL | 25 days |
| Propoxyphene | 625 | ng/mL | 25 days |
| Secobarbital | 375 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 125 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| α-Hydroxyalprazolam | 225 | ng/mL | 25 days |
| Amobarbital | 225 | ng/mL | 25 days |
| d-Amphetamine | 375 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 375 | ng/mL | 25 days |
| d-Methamphetamine | 375 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 375 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 375 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 112.5 | ng/mL | 25 days |
| Butalbital | 225 | ng/mL | 25 days |
| Codeine | 1,500 | ng/mL | 25 days |
| Nordiazepam | 225 | ng/mL | 25 days |
| Hydrocodone | 300 | ng/mL | 25 days |
| Hydromorphone | 300 | ng/mL | 25 days |
| Lorazepam | 225 | ng/mL | 25 days |
| Methadone | 225 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 225 | ng/mL | 25 days |
| Methaqualone | 225 | ng/mL | 25 days |
| Morphine-3-β-D-Glucuronide | 2,430 (Equivalent to 1,500 free Morphine) |
ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 7.5 | ng/mL | 25 days |
| Nortriptyline | 225 | ng/mL | 25 days |
| Oxazepam | 225 | ng/mL | 25 days |
| Oxycodone | 225 | ng/mL | 25 days |
| Oxymorphone | 225 | ng/mL | 25 days |
| Pentobarbital | 225 | ng/mL | 25 days |
| Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
| Phenobarbital | 225 | ng/mL | 25 days |
| Norpropoxyphene | 225 | ng/mL | 25 days |
| Secobarbital | 225 | ng/mL | 25 days |
| Temazepam | 225 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 11.25 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| α-Hydroxyalprazolam | 375 | ng/mL | 25 days |
| Amobarbital | 375 | ng/mL | 25 days |
| d-Amphetamine | 625 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 625 | ng/mL | 25 days |
| d-Methamphetamine | 625 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 625 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 625 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 187.5 | ng/mL | 25 days |
| Butalbital | 375 | ng/mL | 25 days |
| Codeine | 2,500 | ng/mL | 25 days |
| Nordiazepam | 375 | ng/mL | 25 days |
| Hydrocodone (New) | 500 | ng/mL | 25 days |
| Hydromorphone (New) | 500 | ng/mL | 25 days |
| Lorazepam | 375 | ng/mL | 25 days |
| Methadone | 375 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 375 | ng/mL | 25 days |
| Methaqualone | 300 | ng/mL | 25 days |
| Morphine-3-β-D-Glucuronide | 4,050 (Equivalent to 2,500 free Morphine) |
ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 12.5 | ng/mL | 25 days |
| Nortriptyline | 375 | ng/mL | 25 days |
| Oxazepam | 375 | ng/mL | 25 days |
| Oxycodone (New) | 375 | ng/mL | 25 days |
| Oxymorphone (New) | 375 | ng/mL | 25 days |
| Pentobarbital | 375 | ng/mL | 25 days |
| Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
| Phenobarbital | 375 | ng/mL | 25 days |
| Norpropoxyphene | 375 | ng/mL | 25 days |
| Secobarbital | 375 | ng/mL | 25 days |
| Temazepam | 375 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 18.75 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| α-Hydroxyalprazolam | 150 | ng/mL | 25 days |
| Amobarbital | 150 | ng/mL | 25 days |
| d-Amphetamine | 187.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 187.5 | ng/mL | 25 days |
| d-Methamphetamine | 187.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 187.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 187.5 | ng/mL | 25 days |
| Benzoylecgonine | 75 | ng/mL | 25 days |
| Butalbital | 150 | ng/mL | 25 days |
| Codeine | 225 | ng/mL | 25 days |
| Nordiazepam | 150 | ng/mL | 25 days |
| Hydrocodone New | 75 | ng/mL | 25 days |
| Hydromorphone New | 75 | ng/mL | 25 days |
| Lorazepam | 150 | ng/mL | 25 days |
| Methadone | 150 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 150 | ng/mL | 25 days |
| Methaqualone | 150 | ng/mL | 25 days |
| Morphine-3-β-D-Glucuronide | 365 (Equivalent to 225 free Morphine) |
ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 7.5 | ng/mL | 25 days |
| Nortriptyline | 150 | ng/mL | 25 days |
| Oxazepam | 150 | ng/mL | 25 days |
| Oxycodone New | 37.5 | ng/mL | 25 days |
| Oxymorphone New | 37.5 | ng/mL | 25 daus |
| Pentobarbital | 150 | ng/mL | 25 days |
| Phencyclidine (PCP) | 18.75 | ng/mL | 25 days |
| Phenobarbital | 150 | ng/mL | 25 days |
| Norpropoxyphene | 150 | ng/mL | 25 days |
| Secobarbital | 150 | ng/mL | 25 days |
| Temazepam | 150 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 11.25 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| α-Hydroxyalprazolam | 250 | ng/mL | 25 days |
| Amobarbital | 250 | ng/mL | 25 days |
| d-Amphetamine | 312.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyamphetamine (MDA) | 312.5 | ng/mL | 25 days |
| d-Methamphetamine | 312.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 312.5 | ng/mL | 25 days |
| (±)-3,4-Methylenedioxyethylamphetamine (MDEA) | 312.5 | ng/mL | 25 days |
| Benzoylecgonine (BE) | 125 | ng/mL | 25 days |
| Butalbital | 250 | ng/mL | 25 days |
| Codeine | 375 | ng/mL | 25 days |
| Nordiazepam | 250 | ng/mL | 25 days |
| Lorazepam | 250 | ng/mL | 25 days |
| Hydrocodone | 125 | ng/mL | 25 days |
| Hydromorphone | 125 | ng/mL | 25 days |
| Methadone | 250 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 250 | ng/mL | 25 days |
| Methaqualone | 250 | ng/mL | 25 days |
| Morphine-3-β-D-Glucuronide | 608 (Equivalent to 375 free Morphine) |
ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 12.5 | ng/mL | 25 days |
| Nortriptyline | 250 | ng/mL | 25 days |
| Oxazepam | 250 | ng/mL | 25 days |
| Oxycodone | 62.5 | ng/mL | 25 days |
| Oxymorphone | 62.5 | ng/mL | 25 days |
| Pentobarbital | 250 | ng/mL | 25 days |
| Phencyclidine (PCP) | 31.25 | ng/mL | 25 days |
| Phenobarbital | 250 | ng/mL | 25 days |
| Norpropoxyphene | 250 | ng/mL | 25 days |
| Secobarbital | 250 | ng/mL | 25 days |
| Temazepam | 250 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 18.75 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Ethyl-β-D-Glucuronide (EtG) | 500 | ng/mL | 20 days |
| Ethyl Sulfate (EtS) | 200 | ng/mL | 20 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Ethyl-β-D-Glucuronide (EtG) | 2,000 | ng/mL | 20 days |
| Ethyl Sulfate (EtS) | 800 | ng/mL | 20 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| 4-ANPP | 5 | ng/mL | 25 |
| Acetylfentanyl | 5 | ng/mL | 25 |
| Acrylfentanyl | 5 | ng/mL | 25 |
| Alfentanil | 5 | ng/mL | 25 |
| Butyryl Fentanyl | 5 | ng/mL | 25 |
| Carfentanyl | 5 | ng/mL | 25 |
| cis-3-Methylfentanyl | 5 | ng/mL | 25 |
| Crotonylfentanyl | 5 | ng/mL | 25 |
| Fentanyl | 5 | ng/mL | 25 |
| Furanyl Fentanyl | 5 | ng/mL | 25 |
| Isobutyrylfentanyl | 5 | ng/mL | 25 |
| m-Methylmethoxyacetylfentanyl | 5 | ng/mL | 25 |
| Methoxyacetylfentanyl | 5 | ng/mL | 25 |
| Norfentanyl | 5 | ng/mL | 25 |
| Ocfentanyl | 5 | ng/mL | 25 |
| ortho-Fluorofentanyl | 5 | ng/mL | 25 |
| para-Fluorobutyrylfentanyl | 5 | ng/mL | 25 |
| para-Fluoroisobutyrylfentanyl | 5 | ng/mL | 25 |
| para-Fluorofentanyl | 5 | ng/mL | 25 |
| Sufentanil | 5 | ng/mL | 25 |
| Tetrahydrofuran Fentanyl | 5 | ng/mL | 25 |
| U-47700 | 5 | ng/mL | 25 |
| U-49900 | 5 | ng/mL | 25 |
| U51754 | 5 | ng/mL | 25 |
| Valerylfentanyl | 5 | ng/mL | 25 |
| Cyclopropylfentanyl | 5 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Carisoprodol | 500 | ng/mL | 25 days |
| Cocaine | 100 | ng/mL | 25 days |
| Benzoylecgonine | 100 | ng/mL | 25 days |
| Cocaethylene | 100 | ng/mL | 25 days |
| Cyclobenzaprine | 500 | ng/mL | 25 days |
| Meprobamate | 500 | ng/mL | 25 days |
| Methaqualone | 100 | ng/mL | 25 days |
| Methylphenidate | 500 | ng/mL | 25 days |
| Phencyclidine (PCP) | 100 | ng/mL | 25 days |
| Ritalinic Acid | 500 | ng/mL | 25 days |
| Zolpidem | 200 | ng/mL | 25 days |
| (I)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 100 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Carisoprodol | 1,500 | ng/mL | 25 days |
| Cocaine | 300 | ng/mL | 25 days |
| Benzoylecgonine | 300 | ng/mL | 25 days |
| Cocaethylene | 300 | ng/mL | 25 days |
| Cyclobenzaprine | 1,500 | ng/mL | 25 days |
| Meprobamate | 1,500 | ng/mL | 25 days |
| Methaqualone | 300 | ng/mL | 25 days |
| Methylphenidate | 1.500 | ng/mL | 25 days |
| Phencyclidine (PCP) | 300 | ng/mL | 25 days |
| Ritalinic Acid | 1,500 | ng/mL | 25 days |
| Zolpidem | 600 | ng/mL | 25 days |
| (I)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 300 | ng/mL | 25 days |
Pain Management (PM 100)
100% Real Human Matrix Urine Drugs of Abuse Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Buprenorphine | 100 | ng/mL | 25 days |
| Norbuprenorphine | 100 | ng/mL | 25 days |
| Codeine | 100 | ng/mL | 30 days |
| Fentanyl | 10 | ng/mL | 30 days |
| Norfentanyl | 10 | ng/mL | 30 days |
| Hydrocodone | 100 | ng/mL | 30 days |
| Hydromorphone | 100 | ng/mL | 30 days |
| Meperidine | 100 | ng/mL | 30 days |
| Methadone | 100 | ng/mL | 30 days |
| Methadone Primary Metabolite (EDDP) | 100 | ng/mL | 30 days |
| Morphine | 100 | ng/mL | 30 days |
| Oxycodone | 100 | ng/mL | 30 days |
| Oxymorphone | 100 | ng/mL | 30 days |
| Tapentadol | 100 | ng/mL | 25 days |
| Tramadol | 100 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Buprenorphine | 50 | ng/mL | 25 days |
| Norbuprenorphine | 50 | ng/mL | 25 days |
| Codeine | 50 | ng/mL | 25 days |
| Norcodeine | 50 | ng/mL | 25 days |
| Fentanyl | 5 | ng/mL | 25 days |
| Norfentanyl | 5 | ng/mL | 25 days |
| Hydrocodone | 50 | ng/mL | 25 days |
| Norhydrocodone | 50 | ng/mL | 25 days |
| Hydromorphone | 50 | ng/mL | 25 days |
| Meperidine | 50 | ng/mL | 25 days |
| Normeperidine | 50 | ng/mL | 25 days |
| Methadone | 50 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 50 | ng/mL | 25 days |
| Morphine | 50 | ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 5 | ng/mL | 25 days |
| Oxycodone | 50 | ng/mL | 25 days |
| Noroxycodone | 50 | ng/mL | 25 days |
| Oxymorphone | 50 | ng/mL | 25 days |
| Noroxymorphone | 50 | ng/mL | 25 days |
| Tapentadol | 50 | ng/mL | 25 days |
| N-Desmethyltapentadol | 50 | ng/mL | 25 days |
| Tramadol | 50 | ng/mL | 25 days |
| O-Desmethyl-cis-Tramadol | 50 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Buprenorphine | 400 | ng/mL | 25 days |
| Norbuprenorphine | 400 | ng/mL | 25 days |
| Codeine | 400 | ng/mL | 25 days |
| Norcodeine | 400 | ng/mL | 25 days |
| Fentanyl | 40 | ng/mL | 25 days |
| Norfentanyl | 40 | ng/mL | 25 days |
| Hydrocodone | 400 | ng/mL | 25 days |
| Norhydrocodone | 400 | ng/mL | 25 days |
| Hydromorphone | 400 | ng/mL | 25 days |
| Meperidine | 400 | ng/mL | 25 days |
| Normeperidine | 400 | ng/mL | 25 days |
| Methadone | 400 | ng/mL | 25 days |
| Methadone Primary Metabolite (EDDP) | 400 | ng/mL | 25 days |
| Morphine | 400 | ng/mL | 25 days |
| 6-Monoacetylmorphine (6-MAM) | 40 | ng/mL | 25 days |
| Oxycodone | 400 | ng/mL | 25 days |
| Noroxycodone | 400 | ng/mL | 25 days |
| Oxymorphone | 400 | ng/mL | 25 days |
| Noroxymorphone | 400 | ng/mL | 25 days |
| Tapentadol | 400 | ng/mL | 25 days |
| N-Desmethyltapentadol | 400 | ng/mL | 25 days |
| Tramadol | 400 | ng/mL | 25 days |
| O-Desmethyl-cis-Tramadol | 400 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Acetaminophen | 5 | µg/mL | 30 days |
| d-Amphetamine | 2 | µg/mL | 30 days |
| Benzoylecgonine (BE) | 2 | µg/mL | 30 days |
| Codeine | 2 | µg/mL | 30 days |
| Imipramine | 1 | µg/mL | 30 days |
| Methadone | 2 | µg/mL | 30 days |
| Methadone Primary Metabolite (EDDP) | 2 | µg/mL | 30 days |
| Methaqualone | 2 | µg/mL | 30 days |
| Morphine-3-β-D-Glucuronide | 2 | µg/mL | 30 days |
| Oxazepam | 2 | µg/mL | 30 days |
| Phencyclidine (PCP) | 1 | µg/mL | 30 days |
| Phenobarbital | 4 | µg/mL | 30 days |
| Propoxyphene | 4 | µg/mL | 30 days |
| Quinine | 2 | µg/mL | 30 days |
| Secobarbital | 2 | µg/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aluminum | (see insert) | 30 days | |
| Arsenic | (see insert) | 30 days | |
| Cadmium | (see insert) | 30 days | |
| Calcium | (see insert) | 30 days | |
| Chromium | (see insert) | 30 days | |
| Cobalt | (see insert) | 30 days | |
| Copper | (see insert) | 30 days | |
| Creatinine | (see insert) | 30 days | |
| Fluoride | (see insert) | 30 days | |
| Iron | (see insert) | 30 days | |
| Lead | (see insert) | 30 days | |
| Manganese | (see insert) | 30 days | |
| Mercury | (see insert) | 30 days | |
| Molybdenum | (see insert) | 30 days | |
| Nickel | (see insert) | 30 days | |
| Selenium | (see insert) | 30 days | |
| Vanadium | (see insert) | 30 days | |
| Zinc | (see insert) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Aluminum | (see insert) | ng/mL | 30 days |
| Arsenic | (see insert) | ng/mL | 30 days |
| Cadmium | (see insert) | ng/mL | 30 days |
| Calcium | (see insert) | ng/mL | 30 days |
| Chromium | (see insert) | ng/mL | 30 days |
| Cobalt | (see insert) | ng/mL | 30 days |
| Copper | (see insert) | ng/mL | 30 days |
| Creatinine | (see insert) | ng/mL | 30 days |
| Fluoride | (see insert) | ng/mL | 30 days |
| Iron | (see insert) | ng/mL | 30 days |
| Lead | (see insert) | ng/mL | 30 days |
| Manganese | (see insert) | ng/mL | 30 days |
| Mercury | (see insert) | ng/mL | 30 days |
| Molybdenum | (see insert) | ng/mL | 30 days |
| Nickel | (see insert) | ng/mL | 30 days |
| Selenium | (see insert) | ng/mL | 30 days |
| Vanadium | (see insert) | ng/mL | 30 days |
| Zinc | (see insert) | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-Baclofen | 100 | ng/mL | 25 days |
| Dextromethorphan (DXM) | 100 | ng/mL | 25 days |
| Dextrorphan | 300 | ng/mL | 25 days |
| Gabapentin | 2,000 | ng/mL | 25 days |
| Ketamine | 200 | ng/mL | 25 days |
| Norketamine | 200 | ng/mL | 25 days |
| Lamotrigine | 500 | ng/mL | 25 days |
| Mitragynine | 25 | ng/mL | N/A |
| Naloxone | 100 | ng/mL | 25 days |
| Naltrexone | 100 | ng/mL | 25 days |
| 6-β-Naltrexol | 5 | ng/mL | 25 days |
| Pregabalin | 2,000 | ng/mL | 25 days |
| Topiramate | 500 | ng/mL | 25 days |
| Zaleplon | 5 | ng/mL | 25 days |
| Zopiclone | 5 | ng/mL | 25 days |
| Zolpidem | 5 | ng/mL | 25 days |
| Zolpidem Phenyl-4-Carboxylic Acid | 5 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-Baclofen | 300 | ng/mL | 25 days |
| Dextromethorphan (DXM) | 300 | ng/mL | 25 days |
| Dextrorphan | 600 | ng/mL | 25 days |
| Gabapentin | 6,000 | ng/mL | 25 days |
| Ketamine | 600 | ng/mL | 25 days |
| Norketamine | 600 | ng/mL | 25 days |
| Lamotrigine | 1,000 | ng/mL | 25 days |
| Mitragynine | 250 | ng/mL | N/A |
| Naloxone | 300 | ng/mL | 25 days |
| Naltrexone | 300 | ng/mL | 25 days |
| 6-β-Naltrexol | 50 | ng/mL | 25 days |
| Pregabalin | 6,000 | ng/mL | 25 days |
| Zaleplon | 50 | ng/mL | 25 days |
| Zopiclone | 50 | ng/mL | 25 days |
| Zolpidem | 50 | ng/mL | 25 days |
| Zolpidem Phenyl-4-Carboxylic Acid | 50 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Chromium VI | n/a | µg/mL | n/a |
| Creatinine | n/a | mg/dL | n/a |
| Nitrites | 500 - 625 | µg/mL | n/a |
| Oxidants | n/a | µg/mL | n/a |
| pH | 4.5 - 9.0 | n/a | |
| Specific Gravity | 1.0010 - 1.0027 | n/a |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Chromium VI | 0 | µg/mL | n/a |
| Creatinine | 1.0 - 1.5 | mg/dL | n/a |
| Nitrites | 0 | µg/mL | n/a |
| Oxidants | 0 | µg/mL | n/a |
| pH | 3.2 - 4.0 | n/a | |
| Specific Gravity | 1.0210 - 1.0250 | n/a |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Chromium VI | n/a | µg/mL | n/a |
| Creatinine | 3.0 - 4.0 | mg/dL | n/a |
| Nitrites | 200 - 250 | µg/mL | n/a |
| Oxidants | n/a | µg/mL | n/a |
| pH | 10.0 - 10.8 | n/a | |
| Specific Gravity | 0.9950 - 1.0005 | n/a |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Chromium VI | n/a | µg/mL | n/a |
| Creatinine | 21 - 25 | mg/dL | n/a |
| Nitrites | n/a | µg/mL | n/a |
| Oxidants | n/a | µg/mL | n/a |
| pH | 2.0 - 2.8 | n/a | |
| Specific Gravity | 1.0040 - 1.0180 | n/a |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Chromium VI | >65 | µg/mL | n/a |
| Creatinine | n/a | mg/dL | n/a |
| Nitrites | n/a | µg/mL | n/a |
| Oxidants | >65 | µg/mL | n/a |
| pH | 11.2 - 12.0 | n/a | |
| Specific Gravity | n/a | n/a |
Mid Range Barbiturates
Barbiturates Discontinued Products 100% Real Human Matrix Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amobarbital | 4 | µg/mL | 30 days |
| Butalbital | 5 | µg/mL | 30 days |
| Pentobarbital | 4 | µg/mL | 30 days |
| Phenobarbital | 25 | µg/mL | 30 days |
| Secobarbital | 4 | µg/mL | 30 days |
Antihypertensives Level 1
Discontinued Products Matrix 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amlodipine | 10 | ng/mL | 25 |
| Atenolol | 100 | ng/mL | 25 |
| Clonidine | 5 | ng/mL | 25 |
| Furosemide | 200 | ng/mL | 25 |
| Hydrochlorothiazide | 50 | ng/mL | 25 |
| Metoprolol | 100 | ng/mL | 25 |
| Propranolol | 10 | ng/mL | 25 |
Antihypertensives Level 2
Discontinued Products 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amlodipine | 100 | ng/mL | 25 |
| Atenolol | 600 | ng/mL | 25 |
| Clonidine | 50 | ng/mL | 25 |
| Furosemide | 800 | ng/mL | 25 |
| Hydrochlorothiazide | 300 | ng/mL | 25 |
| Metoprolol | 500 | ng/mL | 25 |
| Propranolol | 1,000 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Apixaban | 30 | ng/mL | 25 |
| Dabigartran | 30 | ng/mL | 25 |
| Rivaroxaban | 20 | ng/mL | 25 |
| Salicylic Acid | 80 | µg/mL | 25 |
| Warfarin | 3 | µg/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Apixaban | 350 | ng/mL | 25 |
| Dabigartran | 350 | ng/mL | 25 |
| Rivaroxaban | 300 | ng/mL | 25 |
| Salicylic Acid | 400 | µg/mL | 25 |
| Warfarin | 10 | µg/mL | 25 |
Busulfan Level 1
Plasma Discontinued Products 100% Real Human Matrix Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Busulfan | 350 | ng/mL | 25 Days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Busulfan | 3500 | ng/mL | 25 Days |
High Range Barbiturates
Barbiturates Discontinued Products 100% Real Human Matrix Serum Drugs of Abuse
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amobarbital | 12 | µg/mL | 30 days |
| Butalbital | 15 | µg/mL | 30 days |
| Pentobarbital | 12 | µg/mL | 30 days |
| Phenobarbital | 75 | µg/mL | 30 days |
| Secobarbital | 12 | µg/mL | 30 days |
Mid Range Clonazepam
Benzodiazepines 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Clonazepam | 50 | ng/mL | 30 days |
High Range Clonazepam
Benzodiazepines 100% Real Human Matrix Serum Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Clonazepam | 100 | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Mycophenolic Acid (MPA) | 2 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Mycophenolic Acid (MPA) | 7.5 | µg/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Estazolam | 30 | ng/mL | 25 |
| Temazepam | 100 | ng/mL | 25 |
| Triazolam | 10 | ng/mL | 25 |
| Eszopiclone | 10 | ng/mL | 25 |
| Ramelteon | 10 | ng/mL | 25 |
| Suvorexant | 100 | ng/mL | 25 |
| Zaleplon | 10 | ng/mL | 25 |
| Zolpidem | 10 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Estazolam | 150 | ng/mL | 25 |
| Temazepam | 1,500 | ng/mL | 25 |
| Triazolam | 100 | ng/mL | 25 |
| Eszopiclone | 100 | ng/mL | 25 |
| Ramelteon | 100 | ng/mL | 25 |
| Suvorexant | 600 | ng/mL | 25 |
| Zaleplon | 100 | ng/mL | 25 |
| Zolpidem | 100 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Androstenedione | 0 | ng/mL | 25 days |
| Hydrocortisone (Cortisol) | 0 | µg/dL | 25 days |
| Cortisone | 0 | µg/dL | 25 days |
| Corticosterone | 0 | ng/dL | 25 days |
| 11-Deoxycortisol | 0 | ng/dL | 25 days |
| Dehydroepiandrosterone (DHEA) | 0 | ng/mL | 25 days |
| Progesterone | 0 | ng/mL | 25 days |
| 17α-Hydroxyprogesterone | 0 | µg/dL | 25 days |
| Testosterone | 0 | ng/dL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (-)-Delta-9-THC | 2.5 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC | 25 | ng/mL | 25 days |
| (±)-11-Hydroxy-Delta-9-THC | 2.5 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (-)-Delta-9-THC | 25 | ng/mL | 25 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC | 250 | ng/mL | 25 days |
| (±)-11-Hydroxy-Delta-9-THC | 25 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 0 | ng/mL | 30 days |
| d-Methamphetamine | 0 | ng/mL | 30 days |
| Benzoylecgonine (BE) | 0 | ng/mL | 30 days |
| Methadone | 0 | ng/mL | 30 days |
| Morphine | 0 | ng/mL | 30 days |
| Oxazepam | 0 | ng/mL | 30 days |
| Phencyclidine (PCP) | 0 | ng/mL | 30 days |
| Propoxyphene | 0 | ng/mL | 30 days |
| Secobarbital | 0 | ng/mL | 30 days |
| Delta-9-THC | 0 | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 12.5 | ng/mL | 25 |
| d-Methamphetamine | 12.5 | ng/mL | 25 |
| Benzoylecgonine | 7.5 | ng/mL | 25 |
| Methadone | 25 | ng/mL | 25 |
| Morphine | 15 | ng/mL | 25 |
| Oxazepam | 25 | ng/mL | 25 |
| Oxycodone | 15 | ng/mL | 25 |
| Phencyclidine (PCP) | 1.5 | ng/mL | 25 |
| Delta-9-THC | 2 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 50 | ng/mL | 25 |
| d-Methamphetamine | 50 | ng/mL | 25 |
| Benzoylecgonine | 30 | ng/mL | 25 |
| Methadone | 100 | ng/mL | 25 |
| Morphine | 60 | ng/mL | 25 |
| Oxazepam | 100 | ng/mL | 25 |
| Oxycodone | 60 | ng/mL | 25 |
| Phencyclidine (PCP) | 6 | ng/mL | 25 |
| Delta-9-THC | 8 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Benzoylecgonine | 0 | ng/mL | 14 |
| (-)-Cotinine | 0 | ng/mL | 14 |
| Caffeine | 0 | ng/mL | 14 |
| d-Amphetamine | 0 | ng/mL | 14 |
| d-Methamphetamine | 0 | ng/mL | 14 |
| Ethanol | 0 | ng/mL | 14 |
| Methadone | 0 | ng/mL | 14 |
| Morphine | 0 | ng/mL | 14 |
| Oxazepam | 0 | ng/mL | 14 |
| Oxycodone | 0 | ng/mL | 14 |
| Phencyclidine (PCP) | 0 | ng/mL | 14 |
| Secobarbital | 0 | ng/mL | 14 |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC COOH) |
0 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Benzoylecgonine | 10 | ng/mL | 14 |
| (-)-Cotinine | 2.5 | ng/mL | 14 |
| Caffeine | 10 | ng/mL | 14 |
| d-Amphetamine | 10 | ng/mL | 14 |
| Ethanol | 5 | ng/mL | 14 |
| Methadone | 12.5 | ng/mL | 14 |
| Morphine | 10 | ng/mL | 14 |
| Oxazepam | 50 | ng/mL | 14 |
| Oxycodone | 5 | ng/mL | 14 |
| Phencyclidine (PCP) | 5 | ng/mL | 14 |
| Secobarbital | 40 | ng/mL | 14 |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
5 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Benzoylecgonine | 20 | ng/mL | 14 |
| (-)-Cotinine | 5 | ng/mL | 14 |
| Caffeine | 500 | ng/mL | 14 |
| d-Amphetamine | 20 | ng/mL | 14 |
| d-Methamphetamine | 20 | ng/mL | 14 |
| Ethanol | 10 | ng/mL | 14 |
| Methadone | 25 | ng/mL | 14 |
| Oxazepam | 100 | ng/mL | 14 |
| Oxycodone | 10 | ng/mL | 14 |
| Phencyclidine (PCP) | 10 | ng/mL | 14 |
| Secobarbital | 40 | ng/mL | 14 |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
10 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Benzoylecgonine | 40 | ng/mL | 14 |
| (-)-Cotinine | 10 | ng/mL | 14 |
| Caffeine | 1,000 | ng/mL | 14 |
| d-Amphetamine | 40 | ng/mL | 14 |
| d-Methamphetamine | 40 | ng/mL | 14 |
| Ethanol | 10 | ng/mL | 14 |
| Methadone | 50 | ng/mL | 14 |
| Morphine | 40 | ng/mL | 14 |
| Oxazepam | 200 | ng/mL | 14 |
| Oxycodone | 20 | ng/mL | 14 |
| Phencyclidine (PCP) | 20 | ng/mL | 14 |
| Secobarbital | 80 | ng/mL | 14 |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) |
20 | ng/mL | 14 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cannabigerol (CBG) | 5 | ng/mL | 14 days |
| Cannabinol (CBN) | 5 | ng/mL | 14 days |
| (-)-Delta-9-THC | 5 | ng/mL | 14 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 10 | ng/mL | 14 days |
| (±)-11-Hydroxy-Delta-9-THC | 5 | ng/mL | 14 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cannabigerol | 50 | ng/mL | 14 days |
| Cannabinol | 50 | ng/mL | 14 days |
| (-)-Delta-9-THC | 50 | ng/mL | 14 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 100 | ng/mL | 14 days |
| (±)-11-Hydroxy-Delta-9-THC | 50 | ng/mL | 14 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cannabigerol (CBG) | 100 | ng/mL | 14 days |
| Cannabinol (CBN) | 100 | ng/mL | 14 days |
| (-)-Delta-9-THC | 100 | ng/mL | 14 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) | 200 | ng/mL | 14 days |
| (±)-11-Hydroxy-Delta-9-THC | 100 | ng/mL | 14 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Ethanol | 100 200 300 |
mg/dL | 30 days |
Immunosuppressants (6mL) Level 1
Immunosuppressants 100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 90 | ng/mL | 30 days |
| Everolimus | 4 | ng/mL | 25 days |
| Sirolimus | 4 | ng/mL | 25 days |
| Tacrolimus | 4 | ng/mL | 25 days |
Immunosuppressants Level 2 (6mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 500 | ng/mL | 30 days |
| Everolimus | 15 | ng/mL | 25 days |
| Sirolimus | 15 | ng/mL | 25 days |
| Tacrolimus | 15 | ng/mL | 25 days |
Immunosuppressants Level 3 (6mL)
100% Real Human Matrix Whole Blood Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Cyclosporine | 1,200 | ng/mL | 30 days |
| Everolimus | 25 | ng/mL | 25 days |
| Sirolimus | 25 | ng/mL | 25 days |
| Tacrolimus | 25 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Lead | (see IFU) | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 10 | ng/mL | 25 |
| Gamma-Hydroxybutyric Acid (GHB) | 10 | µg/mL | 25 |
| Flunitrazepam | 10 | ng/mL | 25 |
| Ketamine | 50 | ng/mL | 25 |
| Zaleplon | 10 | ng/mL | 25 |
| Zolpidem | 10 | ng/mL | 25 |
| Zopiclone | 10 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 25 |
| Gamma-Hydroxybutryic Acid (GHB) | 40 | µg/mL | 25 |
| Flunitrazepam | 100 | ng/mL | 25 |
| Ketamine | 200 | ng/mL | 25 |
| Zaleplon | 100 | ng/mL | 25 |
| Zolpidem | 100 | ng/mL | 25 |
| Zopiclone | 100 | ng/mL | 25 |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Butylone | 15 | ng/mL | 14 days |
| Ethylone | 15 | ng/mL | 14 days |
| Mephedrone | 15 | ng/mL | 14 days |
| *Methedrone | 15 | ng/mL | 14 days |
| Methylone | 15 | ng/mL | 14 days |
| 3,4-Methylenedioxypyrovalerone (MDPV) | 15 | ng/mL | 14 days |
| α-Pyrrolidinovalerophenone (α-PVP) | 15 | ng/mL | 14 days |
Barbiturates Panel Level 1
Barbiturates Discontinued Products 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amobarbital | 750 | ng/mL | 25 days |
| Butabarbital | 750 | ng/mL | 25 days |
| Butalbital | 750 | ng/mL | 25 days |
| Pentobarbital | 750 | ng/mL | 25 days |
| Phenobarbital | 750 | ng/mL | 25 days |
| Secobarbital | 750 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amobarbital | 1,500 | ng/mL | 25 days |
| Butabarbital | 1,500 | ng/mL | 25 days |
| Butalbital | 1,500 | ng/mL | 25 days |
| Pentobarbital | 1,500 | ng/mL | 25 days |
| Phenobarbital | 1,500 | ng/mL | 25 days |
| Secobarbital | 1,500 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| d-Amphetamine | 0 | ng/mL | 30 days |
| d-Methamphetamine | 0 | ng/mL | 30 days |
| Benzoylecgonine (BE) | 0 | ng/mL | 30 days |
| Morphine | 0 | ng/mL | 30 days |
| Oxazepam | 0 | ng/mL | 30 days |
| (l)-9-Carboxy-11-nor-Delta-9-THC | 0 | ng/mL | 30 days |
| Other* | 0 | ng/mL | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 100 | ng/mL | 25 days |
| Dextromethorphan (DXM) | 50 | ng/mL | 25 days |
| Dimethyltryptamine (DMT) | 50 | ng/mL | 25 days |
| Ketamine | 50 | ng/mL | 25 days |
| Lysergic Acid Diethylamide (LSD) | 5 | ng/mL | 25 days |
| Mescaline | 50 | ng/mL | 25 days |
| Mitragynine | 50 | ng/mL | 25 days |
| Phencyclidine (PCP) | 10 | ng/mL | 25 days |
| Psilocybin | 50 | ng/mL | 25 days |
| Salvinorin A | 5 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| (±)-3,4-Methylenedioxymethamphetamine (MDMA) | 300 | ng/mL | 25 days |
| Dextromethorphan (DXM) | 200 | ng/mL | 25 days |
| Dimethyltryptamine (DMT) | 200 | ng/mL | 25 days |
| Ketamine | 200 | ng/mL | 25 days |
| Lysergic Acid (LSD) | 20 | ng/mL | 25 days |
| Mescaline | 200 | ng/mL | 25 days |
| Mitragynine | 200 | ng/mL | 25 days |
| Phencyclidine (PCP) | 100 | ng/mL | 25 days |
| Psilocybin | 200 | ng/mL | 25 days |
| Salvinorin A | 20 | ng/mL | 25 days |
Nicotine Plus Level 1
Discontinued Products 100% Real Human Matrix Urine Nicotine / Alkaloids
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Nicotine | 100 | ng/mL | 20 days |
| Anabasine | 100 | ng/mL | 20 days |
| (-)-Cotinine | 100 | ng/mL | 20 days |
| trans-3-Hydroxy Cotinine | 100 | ng/mL | 20 days |
| Nornicotine | 100 | ng/mL | 20 days |
Nicotine Plus Level 2
Discontinued Products 100% Real Human Matrix Urine Nicotine / Alkaloids
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Nicotine | 1,000 | ng/mL | 20 days |
| Anabasine | 1,000 | ng/mL | 20 days |
| (-)-Cotinine | 1,000 | ng/mL | 20 days |
| trans-3-Hydroxy Cotinine | 1,000 | ng/mL | 20 days |
| Nornicotine | 1,000 | ng/mL | 20 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Creatinine | 21 - 35 | mg/dL | 30 days |
| Specific Gravity | >1.003 | ng/mL | 30 days |
| pH | 2 - 3 | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Creatinine | 21 - 35 | mg/dL | 30 days |
| Specific Gravity | >1.003 | ng/mL | 30 days |
| pH | 11 - 12 | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| AM2201 N-(4-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 018 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 073 N-(4-Hydroxybutyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 081 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 122 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 210 N-(5-Carboxypentyl) Metabolite | 15 | ng/mL | 14 days |
| JWH 250 4-Hydroxypentyl Metabolite | 15 | ng/mL | 14 days |
| MAM2201 N-Pentanoic Acid Metabolite | 15 | ng/mL | 14 days |
| RCS-4 M9 Metabolite | 15 | ng/mL | 14 days |
| RCS-4 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| UR-144 N-(5-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| XLR11 N-(4-Hydroxypentyl) Metabolite | 15 | ng/mL | 14 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| AM2201 N-(4-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| JWH 018 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| JWH 073 N-(4-Hydroxybutyl) Metabolite | 150 | ng/mL | 14 days |
| **JWH 081 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| JWH 122 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| JWH 210 N-(5-Carboxypentyl) Metabolite | 150 | ng/mL | 14 days |
| JWH 250 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| MAM2201 N-Pentanoic Acid Metabolite | 150 | ng/mL | 14 days |
| RCS-4 M9 Metabolite | 150 | ng/mL | 14 days |
| RCS-4 N-(5-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| UR-144 5-Hydroxypentyl Metabolite | 150 | ng/mL | 14 days |
| XLR11 N-(4-Hydroxypentyl) Metabolite | 150 | ng/mL | 14 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Bupropion | 100 | ng/mL | 25 days |
| Hydroxybupropion | 150 | ng/mL | 25 days |
| Citalopram | 100 | ng/mL | 25 days |
| N-Desmethylcitalopram | 100 | ng/mL | 25 days |
| Duloxetine | 100 | ng/mL | 25 days |
| Fluvoxamine | 100 | ng/mL | 25 days |
| Nefazodone | 300 | ng/mL | 25 days |
| Paroxetine | 100 | ng/mL | 25 days |
| Sertraline | 100 | ng/mL | 25 days |
| Desmethylsertraline | 100 | ng/mL | 25 days |
| Venlafaxine | 100 | ng/mL | 25 days |
| O-Desmethylvenlafaxine | 100 | ng/mL | 25 days |
SSRI 12 Level 2
Discontinued Products 100% Real Human Matrix Urine SSRI Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Bupropion | 600 | ng/mL | 25 days |
| Hydroxybupropion | 900 | ng/mL | 25 days |
| Citalopram | 300 | ng/mL | 25 days |
| N-Desmethylcitalopram | 300 | ng/mL | 25 days |
| Duloxetine | 500 | ng/mL | 25 days |
| Fluvoxamine | 900 | ng/mL | 25 days |
| Nefazodone | 900 | ng/mL | 25 days |
| Paroxetine | 500 | ng/mL | 25 days |
| Sertraline | 300 | ng/mL | 25 days |
| Desmethylsertraline | 300 | ng/mL | 25 days |
| Venlafaxine | 500 | ng/mL | 25 days |
| O-Desmethylvenlafaxine | 500 | ng/mL | 25 days |
TCA Panel Level 1
Discontinued Products 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | 150 | ng/mL | 25 days |
| Amoxapine | 150 | ng/mL | 25 days |
| Clomipramine | 150 | ng/mL | 25 days |
| Desmethylclomipramine | 150 | ng/mL | 25 days |
| Doxepin | 150 | ng/mL | 25 days |
| Desmethyldoxepin | 150 | ng/mL | 25 days |
| Fluoxetine | 150 | ng/mL | 25 days |
| Norfluoxetine | 150 | ng/mL | 25 days |
| Imipramine | 150 | ng/mL | 25 days |
| Desipramine | 150 | ng/mL | 25 days |
| Maprotiline | 150 | ng/mL | 25 days |
| Mirtazapine | 150 | ng/mL | 25 days |
| Nortriptyline | 150 | ng/mL | 25 days |
| Protriptyline | 150 | ng/mL | 25 days |
| Trazodone | 300 | ng/mL | 25 days |
| Trimipramine | 150 | ng/mL | 25 days |
| Desmethyltrimipramine | 150 | ng/mL | 25 days |
TCA Panel Level 2
Discontinued Products 100% Real Human Matrix Urine Theraputic Drug Monitoring (TDM)
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Amitriptyline | 400 | ng/mL | 25 days |
| Amoxapine | 400 | ng/mL | 25 days |
| Clomipramine | 400 | ng/mL | 25 days |
| Desmethylclomipramine | 400 | ng/mL | 25 days |
| Doxepin | 400 | ng/mL | 25 days |
| Desmethyldoxepin | 400 | ng/mL | 25 days |
| Fluoxetine | 400 | ng/mL | 25 days |
| Norfluoxetine | 400 | ng/mL | 25 days |
| Imipramine | 400 | ng/mL | 25 days |
| Desipramine | 400 | ng/mL | 25 days |
| Maprotiline | 400 | ng/mL | 25 days |
| Mirtazapine | 400 | ng/mL | 25 days |
| Nortriptyline | 400 | ng/mL | 25 days |
| Protriptyline | 400 | ng/mL | 25 days |
| Trazodone | 800 | ng/mL | 25 days |
| Trimipramine | 400 | ng/mL | 25 days |
| Desmethyltrimipramine | 400 | ng/mL | 25 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Creatinine | <5 | mg/dL | 30 days |
| Specific Gravity | ≤1.001 | 30 days | |
| Nitrites | Negative | µg/mL | 30 days |
| pH | 6 - 7 | 30 days |
| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Creatinine | 10 - 19 | mg/dL | 30 days |
| Specific Gravity | ≤1.003 | 30 days | |
| Nitrites | 400 | ng/mL | 30 days |
| pH | 6 - 7 | 30 days |
High Range Validity Check
Discontinued Products 100% Real Human Matrix Urine Urinary Modifier
Learn More| Analyte | Gravimetrically Weighted Value | Units | Reconstituted Stability (Days) |
|---|---|---|---|
| Creatinine | 21 - 35 | mg/dL | 30 days |
| Specific Gravity | >1.003 | 30 days | |
| Nitrites | 600 | ng/mL | 30 days |
| pH | 6 - 7 | 30 days |